1. Home
  2. ONC vs LVS Comparison

ONC vs LVS Comparison

Compare ONC & LVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$322.01

Market Cap

31.4B

Sector

Health Care

ML Signal

HOLD

Logo Las Vegas Sands Corp.

LVS

Las Vegas Sands Corp.

HOLD

Current Price

$49.55

Market Cap

31.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONC
LVS
Founded
2010
1988
Country
Switzerland
United States
Employees
12000
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
31.4B
31.2B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
ONC
LVS
Price
$322.01
$49.55
Analyst Decision
Strong Buy
Buy
Analyst Count
10
14
Target Price
$385.10
$69.21
AVG Volume (30 Days)
354.8K
4.7M
Earning Date
05-06-2026
04-22-2026
Dividend Yield
N/A
2.23%
EPS Growth
N/A
19.90
EPS
N/A
1.38
Revenue
N/A
$13,017,000,000.00
Revenue This Year
$723.76
$7.24
Revenue Next Year
$15.04
$4.49
P/E Ratio
$614.06
$35.18
Revenue Growth
N/A
15.22
52 Week Low
$253.95
$44.21
52 Week High
$385.22
$70.45

Technical Indicators

Market Signals
Indicator
ONC
LVS
Relative Strength Index (RSI) 67.74 59.91
Support Level $325.47 $48.24
Resistance Level $328.39 $54.81
Average True Range (ATR) 8.03 1.12
MACD 1.40 0.50
Stochastic Oscillator 87.66 94.97

Price Performance

Historical Comparison
ONC
LVS

About ONC BeiGene Ltd. American Depositary Shares

BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.

About LVS Las Vegas Sands Corp.

Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, Sands generates all its EBITDA from Asia, with its casino operations generating the majority of sales.

Share on Social Networks: